• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Severe dyspnoea in a patient with chronic myelogenous leukaemia on a tyrosine kinase inhibitor.

作者信息

Ustun Celalettin, Randall Nicole, Podgaetz Eitan, Amin Khalid, Dincer H Erhan

机构信息

Division of Hematology, Oncology and Transplantation, Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA.

Division of Cardiothoracic Surgery, Department of Surgery, University of Minnesota, Minneapolis, Minnesota, USA.

出版信息

Thorax. 2015 Jul;70(7):701-4. doi: 10.1136/thoraxjnl-2015-206841. Epub 2015 May 2.

DOI:10.1136/thoraxjnl-2015-206841
PMID:25935168
Abstract
摘要

相似文献

1
Severe dyspnoea in a patient with chronic myelogenous leukaemia on a tyrosine kinase inhibitor.一名正在服用酪氨酸激酶抑制剂的慢性粒细胞白血病患者出现严重呼吸困难。
Thorax. 2015 Jul;70(7):701-4. doi: 10.1136/thoraxjnl-2015-206841. Epub 2015 May 2.
2
Dasatinib: a tyrosine kinase inhibitor for the treatment of chronic myelogenous leukemia and philadelphia chromosome-positive acute lymphoblastic leukemia.达沙替尼：一种用于治疗慢性粒细胞白血病和费城染色体阳性急性淋巴细胞白血病的酪氨酸激酶抑制剂。
Clin Ther. 2007 Nov;29(11):2289-308. doi: 10.1016/j.clinthera.2007.11.005.
3
Dasatinib, large granular lymphocytosis, and pleural effusion: useful or adverse effect?达沙替尼、大颗粒淋巴细胞增多症和胸腔积液：有益还是有害作用？
Crit Rev Oncol Hematol. 2014 Feb;89(2):242-7. doi: 10.1016/j.critrevonc.2013.10.005. Epub 2013 Oct 12.
4
Dasatinib in chronic myelogenous leukemia.达沙替尼用于慢性粒细胞白血病
N Engl J Med. 2006 Sep 7;355(10):1062; author reply 1063-4. doi: 10.1056/NEJMc061882.
5
Dasatinib-induced pleural effusions: a lymphatic network disorder?达沙替尼诱导的胸腔积液：一种淋巴管网络紊乱？
Am J Med Sci. 2009 Nov;338(5):414-7. doi: 10.1097/MAJ.0b013e3181ae9227.
6
Lung abnormalities after dasatinib treatment for chronic myeloid leukemia: a case series.达沙替尼治疗慢性粒细胞白血病后的肺部异常：病例系列
Am J Respir Crit Care Med. 2007 Oct 15;176(8):814-8. doi: 10.1164/rccm.200705-715CR. Epub 2007 Jun 28.
7
The combination of thymosin and methylprednisolone for the treatment of a patient with colonic ulcers, subcutaneous nodules, and pleural effusion after dasatinib treatment for chronic myeloid leukemia.胸腺素与甲泼尼龙联合用于治疗一名慢性髓性白血病患者，该患者在接受达沙替尼治疗后出现结肠溃疡、皮下结节和胸腔积液。
Leuk Lymphoma. 2010 May;51(5):941-3. doi: 10.3109/10428191003682783.
8
Pleural and pericardial effusions in chronic myeloid leukemia patients receiving low-dose dasatinib therapy.接受低剂量达沙替尼治疗的慢性髓性白血病患者的胸腔和心包积液
Haematologica. 2011 Mar;96(3):e15; author reply e16-7. doi: 10.3324/haematol.2011.040048.
9
The occurrence and management of fluid retention associated with TKI therapy in CML, with a focus on dasatinib.TKI 治疗相关 CML 液体潴留的发生和管理，重点是达沙替尼。
J Hematol Oncol. 2009 Nov 12;2:46. doi: 10.1186/1756-8722-2-46.
10
The incidence of pleural and pericardial effusion is not higher in patients receiving dasatinib at low doses. (Reply).
Haematologica. 2011 Apr;96(4):e23-4; author reply e25. doi: 10.3324/haematol.2011.041319.

引用本文的文献

1
Tyrosine Kinase Inhibitor-associated Fibrothorax.酪氨酸激酶抑制剂相关纤维胸
Am J Respir Crit Care Med. 2019 Jun 1;199(11):1432. doi: 10.1164/rccm.201806-1155IM.
2
Pleural adverse drugs reactions and protein kinase inhibitors: Identification of suspicious targets by disproportionality analysis from VigiBase.胸膜不良反应与蛋白激酶抑制剂：基于 VigiBase 的比例失调分析鉴定可疑靶标。
Br J Clin Pharmacol. 2018 Oct;84(10):2373-2383. doi: 10.1111/bcp.13693. Epub 2018 Aug 5.
3
Dasatinib-induced pulmonary arterial hypertension.达沙替尼致肺动脉高压。
Br J Clin Pharmacol. 2018 May;84(5):835-845. doi: 10.1111/bcp.13508. Epub 2018 Mar 6.